Medicine Research Websites
The Trivedi Effect: Mahendra Trivedi Science Projects Researches
Mahendra Trivedi Science is all about scientific experiments, researches and studies by Mahendra Kumar Trivedi. The Trivedi Effect is a unique phenomenon worked in agriculture, biotechnology, genetics, materials science and microbiology etc.
CBD may help avert lung destruction in COVID-19
Cannabidiol, or CBD, may help reduce the cytokine storm and excessive lung inflammation that is killing many patients with COVID-19, researchers say.
Byl719 Inhibitor – BYL719 is an alpha-specific PI3K inhibitor.
byl719 inhibitor is taken by mouth.
R428 Inhibitor – R428 is an experimental oral small molecule that is an inhibitor of AXL kinase.
R428 inhibitor is currently undergoing Phase II clinical trials for non small cell lung cancer.
A 1331852 Inhibitor – A 1331852 inhibitor is a target of various senolytic agents.
A 1331852 inhibitor is a member of the Bcl 2 family of proteins.
Ap26113 Inhibitor – Ap26113 acts as both an anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR) inhibitor.
Ap26113 inhibitor is an inhibitor of ALK and mutated EGFR.
Mdivi 1 Inhibitor – Mdivi 1 exists as homooligomers and its function relies on its oligomerization ability.
Mdivi 1 inhibitor a GTPase that regulates mitochondrial fission.
ITF2357 inhibitor – ITF2357 was discovered at Italfarmaco of Milan, Italy. It was patented in 1997 and first described in the scientific literature in 2005.
Givinostat is in numerous phase II clinical trials
Adagrasib Inhibitor – Adagrasib is an inhibitor of the RAS GTPase family.
Adagrasib inhibitor is an anticancer medication used to treat non-small cell lung cancer.
Deferoxamine Inhibitor – Deferoxamine is a siderophore from the bacteria Streptomyces pilosus.
Deferoxamine inhibitor is a medication that binds iron and aluminium.